TY - JOUR
T1 - Pattern recognition receptor signaling in human dendritic cells is enhanced by ICOS ligand and modulated by the crohn's disease ICOSLG risk allele
AU - Hedl, Matija
AU - Lahiri, Amit
AU - Ning, Kaida
AU - Cho, Judy H.
AU - Abraham, Clara
N1 - Funding Information:
This work was supported by the Broad Foundation and the NIH: R01DK099097, R01DK077905, R56AI089789, U01 DK062422, U01 DK62429, DK099097, R01 DK092235, DK-P30-34989, U19-AI082713, U01 DK62429, U01 DK062422, R01 DK092235.
PY - 2014/5/15
Y1 - 2014/5/15
N2 - Inflammatory bowel disease (IBD) is characterized by dysregulated intestinal immune homeostasis and cytokine secretion. Multiple loci are associated with IBD, but a functional explanation is missing for most. Here we found that pattern-recognition receptor (PRR)-induced cytokine secretion was diminished in human monocyte-derived dendritic cells (MDDC) from rs7282490 ICOSLG GG risk carriers. Homotypic interactions between the costimulatory molecule ICOS and the ICOS ligand on MDDCs amplified nucleotide-binding oligomerization domain 2 (NOD2)-initiated cytokine secretion. This amplification required arginine residues in the ICOSL cytoplasmic tail that recruited the adaptor protein RACK1 and the kinases PKC and JNK leading to PKC, MAPK, and NF-κB activation. MDDC from rs7282490 GG risk-carriers had reduced ICOSL expression and PRR-initiated signaling and this loss-of-function ICOSLG risk allele associated with an ileal Crohn's disease phenotype, similar to polymorphisms in NOD2. Taken together, ICOSL amplifies PRR-initiated outcomes, which might contribute to immune homeostasis.
AB - Inflammatory bowel disease (IBD) is characterized by dysregulated intestinal immune homeostasis and cytokine secretion. Multiple loci are associated with IBD, but a functional explanation is missing for most. Here we found that pattern-recognition receptor (PRR)-induced cytokine secretion was diminished in human monocyte-derived dendritic cells (MDDC) from rs7282490 ICOSLG GG risk carriers. Homotypic interactions between the costimulatory molecule ICOS and the ICOS ligand on MDDCs amplified nucleotide-binding oligomerization domain 2 (NOD2)-initiated cytokine secretion. This amplification required arginine residues in the ICOSL cytoplasmic tail that recruited the adaptor protein RACK1 and the kinases PKC and JNK leading to PKC, MAPK, and NF-κB activation. MDDC from rs7282490 GG risk-carriers had reduced ICOSL expression and PRR-initiated signaling and this loss-of-function ICOSLG risk allele associated with an ileal Crohn's disease phenotype, similar to polymorphisms in NOD2. Taken together, ICOSL amplifies PRR-initiated outcomes, which might contribute to immune homeostasis.
UR - http://www.scopus.com/inward/record.url?scp=84900389558&partnerID=8YFLogxK
U2 - 10.1016/j.immuni.2014.04.011
DO - 10.1016/j.immuni.2014.04.011
M3 - Article
C2 - 24837102
AN - SCOPUS:84900389558
SN - 1074-7613
VL - 40
SP - 734
EP - 746
JO - Immunity
JF - Immunity
IS - 5
ER -